Our brand new website for Guardant Health Asia, Middle East and Africa (AMEA) has officially gone “live”. Visit us today at https://www.guardanthealthamea.com.

With this launch, we aim to create awareness among oncologists and advanced cancer patients about Guardant360®, the global leader in comprehensive liquid biopsy.

The Guardant360® assay is a breakthrough liquid biopsy that provides fast, accurate and comprehensive genomic results from a simple blood draw in approximately seven days upon receipt in the US laboratory. Since its launch in 2014, the Guardant360® assay has been ordered by more than 6,000 oncologists over 100,000 times for cancer patients with advanced solid tumors.

In the heart of everything we do, at Guardant Health AMEA, we are dedicated to finding the most appropriate treatment for every patient’s unique cancer type.

Bookmark our webpage today: https://www.guardanthealthamea.com.